Potential applications of human saliva as diagnostic fluid;Le potenziali applicazioni della saliva umana come fluido diagnostico

Acta Otorhinolaryngologica Italica

Volumn 31, Issue 6, 2011, Pages 347-357

  Castagnola, M ^a   Picciotti, Pasqualina Maria ^a   Messana, I ^b   Fanali, C ^a   Fiorita, A ^a   Cabras, T ^a   Calo L ^a   Pisano, E ^b   Passali, G C ^a   Iavarone, F ^a   Paludetti, G ^a   Scarano, E ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Dental pathology; Oncology; Oral cavity; Peptides; Proteins; Proteomics; Saliva; Salivary glands; Systemic diseases; Therapy

Indexed keywords

SALIVA PROTEIN;

CHEMISTRY; DIAGNOSTIC TEST; HUMAN; MOUTH DISEASE; NEOPLASM; REVIEW; SALIVA;

DIAGNOSTIC TESTS, ROUTINE; HUMANS; MOUTH DISEASES; NEOPLASMS; SALIVA; SALIVARY PROTEINS AND PEPTIDES;

EID: 84856775469     PISSN: 0392100X     EISSN: 1827675X     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. Humphrey SP, Williamson RT. A review of saliva: normal composition, flow, and function. J Prosthet Dent 2001;85:162-9.
2. Edgar WM. Saliva: its secretion, composition and functions. Br Dent J 1992;172:305-12.
3. Lawrence HP. Salivary markers of systemic disease: noninvasive diagnosis of disease and monitoring of general health. J Can Dent Assoc 2002;68:170-4.
4. de Almeida Pdel V, Grégio AM, Machado MA, et al. Saliva composition and functions: a comprehensive review. J Contemp Dent Pract 2008;9:72-80.
5. Yeh CK, Christodoulides NJ, Floriano PN, et al. Current development of saliva/oral fluid-based diagnostics. Tex Dent J 2010;127:651-61.
6. Spielmann N, Wong D. Saliva: diagnostics and therapeutic perspectives. Oral Dis 2011;17:345-54.
7. Castagnola M, Cabras T, Vitali A, et al. Biotechnological implications of the salivary proteome. Trends Biotechnol 2011;29:409-18.
8. Helmerhorst EJ, Oppenheim FG. Saliva: a dynamic proteome. J Dent Res 2007;86:680-93.
9. Wu ZZ, Wang JG, Zhang XL. Diagnostic model of saliva protein finger print analysis of patients with gastric cancer. World J Gastroenterol 2009;15:865-70.
10. Giardina B, Messana I, Scatena R, et al. The multiple function of hemoglobin. Crit Re Biochem Mol Biol 1995;30:165-96.
11. Inzitari R, Vento G, Capoluongo E, et al. Proteomic analysis of salivary acidic proline-rich proteins in human preterm and at-term newborns. J Proteome Res 2007;6:1371-7.
12. Cabras T, Pisano E, Boi R, et al. Age-dependent modifications of the human salivary secretory protein complex. J Proteome Res 2009;8:4126-34.
13. Veerman EC, van der Keybus PA, Vissink A, et al. Human glandular salivas: their separate collection and analysis. Eur J Oral Sci 1996;104:346-52.
14. Messana I, Cabras T, Pisano E, et al. Trafficking and postsecretory events responsible for the formation of secreted human salivary peptides. A proteomic approach. Mol Cell Proteomics 2008;7:911-26.
15. Hu S, Arellano M, Boontheung P, et al. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res 2008;14:6246-52.
16. Hardt M, Thomas LR, Dixon SE, et al. Toward defining the human parotid gland salivary proteome and peptidome: identification and characterization using 2D SDS-PAGE, ultrafiltration, HPLC, and mass spectrometry. Biochemistry 2005;44:2885-99.
17. Patamia M, Messana I, Petruzzelli R, et al. Two proline-rich peptides from pig (Sus scrofa) salivary glands generated by pre-secretory pathway underlying the action of a proteinase cleaving ProAla bonds. Peptides 2005;26:1550-9.
18. Fanali C, Inzitari R, Cabras T, et al. Mass spectrometry strategies applied to the characterization of proline-rich peptides from secretory parotid granules of pig (Sus scrofa). J Sep Sci 2008;31:516-22.
19. Cabras T, Fanali C, Monteiro JA, et al. Tyrosine polysulfation of human salivary histatin 1. A post-translational modification specific of the submandibular gland. J Proteome Res 2007;6:2472-80.
20. Castagnola M, Inzitari R, Rossetti DV, et al. A cascade of 24 histatins (histatin 3 fragments) in human saliva. Suggestions for a pre-secretory sequential cleavage pathway. J Biol Chem 2004;279:41436-43.
21. Messana I, Cabras T, Inzitari R, et al. Characterization of the human salivary basic proline-rich protein complex by a proteomic approach. J Proteome Res 2004;3:792-800.
22. Inzitari R, Cabras T, Rossetti DV, et al. Detection in human saliva of different statherin and P-B fragments and derivatives. Proteomics 2006;6:6370-9.
23. Cabras T, Inzitari R, Fanali C, et al. HPLC-MS characterization of cyclo-statherin Q-37, a specific cyclization product of human salivary statherin generated by transglutaminase 2. J Sep Sci 2006;29:2600-8.
24. Siqueira WL, Salih E, Wan DL, et al. Proteome of human minor salivary gland secretion. J Dent Res 2008;87:445-50.
25. Gonzalez-Begne M, Lu B, Han X, et al. Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). J Proteome Res 2009;8:1304-14.
26. Nakashima D, Uzawa K, Kasamatsu A, et al. Protein expression profiling identifies maspin and stathmin as potential biomarkers of adenoid cystic carcinoma of the salivary glands. Int J Cancer 2006;118:704-13.
27. Contucci AM, Inzitari R, Agostino S, et al. Statherin levels in saliva of patients with precancerous and cancerous lesions of the oral cavity: a preliminary report. Oral Dis 2005;11:95-9.
28. An J, Sun JY, Yuan Q, et al. Proteomics analysis of differentially expressed metastasis-associated proteins in adenoid cystic carcinoma cell lines of human salivary gland. Oral Oncol 2004;40:400-8.
29. Bigler LR, Streckfus CF, Dubinsky WP. Salivary biomarkers for the detection of malignant tumors that are remote from the oral cavity. Clin Lab Med 2009;29:71-85.
30. Lekholm U, Wallenius K. Experimental oral cancer in rats with xerostomia. Odontol Rev 1976;27:11-8.
31. Dayan D, Hirshberg A, Kaplan I, et al. Experimental tongue cancer in desalivated rats. Oral Oncol 1997;33:105-9.
32. Ohshiro K, Rosenthal DI, Koomen JM, et al. Pre-analytic saliva processing affects proteomic results and biomarker screening of head and neck squamous carcinoma. Int J Oncol 2007;30:743-9.
33. Dowling P, Wormald R, Meleady P, et al. Analysis of the saliva proteome from patients with head and neck squamous cell carcinoma reveals differences in abundance levels of proteins associated with tumour progression and metastasis. J Proteomics 2008;71:168-75.
34. Maier H, Born IA, Veith S, et al. The effect of chronic ethanol consumption on salivary gland morphology and function in the rat. Alcohol Clin Exp Res 1986;10:425-7.
35. Mizukawa N, Sawaki K, Nagatsuka H, et al. Human alphaand beta-defensin immunoreactivity in oral mucoepidermoid carcinomas. Anticancer Res 2001;21:2171-4.
36. Pickering V, Jordan RC, Schmidt BL. Elevated salivary endothelin levels in oral cancer patients-a pilot study. Oral Oncol 2007;43:37-41.
37. Wong DT. Toward a simple, saliva-based test for the detection of oral cancer. Expert Rev Mol Diagn 2006;6:267-72.
38. Xie H, Onsongo G, Popko J, et al. Proteomics analysis of cells in whole saliva from oral cancer patients via valueadded three-dimensional peptide fractionation and tandem mass spectrometry. Mol Cell Proteomics 2008;7:486-98.
39. Hu S, Denny P, Denny P, et al. Differentially expressed protein markers in human submandibular and sublingual secretions. Int J Oncol 2004;25:1423-30.
40. Tomasik A, Tarnawski R, Tarnawski R, et al. Measurements of amylase isoenzymes in sera and saliva of patients after radiotherapy because of larynx carcinoma Otolaryngol Pol 1994;48:132-7.
41. Streckfus C, Bigler L, Dellinger T, Dai X, et al. The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study. Clin Cancer Res 2000;6:2363-70.
42. Tabak LA. A revolution in biomedical assessment: the development of salivary diagnostic. J Dent Educ 2001;65:1335-9.
43. Wu Y, Shu R, Luo LJ, et al. Initial comparison of proteomic profiles of whole unstimulated saliva obtained from generalized aggressive periodontitis patients and healthy control subjects. Periodontal Res 2009;44:63644.
44. Giusti L, Baldini C, Bazzichi L, et al. Proteome analysis of whole saliva: a new tool for rheumatic diseases-the example of Sjögren's syndrome. Proteomics 2007;7:1634-43.
45. Ryu OH, Atkinson JC, Hoehn GT, et al. Identification of parotid salivary biomarkers in Sjogren's syndrome by surfaceenhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis. Rheumatology (Oxford) 2006;45:1077-86.
46. Stea EA, Routsias JG, Samiotaki M, et al. Analysis of parotid glands of primary Sjögren's syndrome patients using proteomic technology reveals altered autoantigen composition and novel antigenic targets. Clin Exp Immunol 2007;147:81-9.
47. Peluso G, De Santis M, Inzitari R, et al. Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and after pilocarpine treatment. Arthritis Rheum 2007;56:2216-22.
48. Rigante D, Inzitari R, Carone M, et al. Correspondence be tween clinical improvement and proteomic changes of the salivary peptide complex in a child with primary Sjögren syndrome. Rheumatol Int 2008;28:801-6.
49. Van Nieuw Amerongen A, Bolscher JG, Veerman EC. Salivary proteins: protective and diagnostic value in cariology? Caries Res 2004;38:247-53.
50. Dowd FJ. Saliva and dental caries. Dent Clin North Am 1999;43:579-97.
51. Ligtenberg AJ, de Soet JJ, Veerman EC, et al. Oral diseases: from detection to diagnostics. Ann N Y Acad Sci 2007;1098:200-3.
52. Chiappin S, Antonelli G, Gatti R, et al. Saliva specimen: a new laboratory tool for diagnostic and basic investigation. Clin Chim Acta 2007;383:30-40.
53. Vitorino R, de Morais Guedes S, Ferreira R, et al. Two-dimensional electrophoresis study of in vitro pellicle formation and dental caries susceptibility. Eur J Oral Sci 2006;114:147-53.
54. Ito T, Komiya-Ito A, Arataki T, et al. Relationship between antimicrobial protein levels in whole saliva and periodontitis. J Periodontol 2008;79:316-22.
55. Fábián TK, Fejérdy P, Nguyen MT, et al. Potential immunological functions of salivary Hsp70 in mucosal and periodontal defense mechanisms. Arch Immunol Ther Exp 2007;55:91-8.
56. Fábián TK, Fejérdy P, Csermely P. Salivary genomics, transcriptomics and proteomics: the emerging concept of the oral ecosystem and their use in the early diagnosis of cancer and other diseases. Curr Genomics 2008;9:11-21.
57. Kibayashi M, Tanaka M, Nishida N, et al. Longitudinal study of the association between smoking as a periodontitis risk and salivary biomarkers related to periodontitis. J Periodontol 2007;78:859-67.
58. Nishida N, Yamamoto Y, Tanaka M, et al. Association between passive smoking and salivary markers related to periodontitis. J Clin Periodontol 2006;33:717-23.
59. Pisano E, Cabras T, Montaldo C, et al. Peptides of human gingival crevicular fluid determined by HPLC-ESI-MS. Eur J Oral Sci 2005;113:462-8.
60. Rudney JD, Staikov RK, Johnson JD. Potential biomarkers of human salivary function: a modified proteomic approach. Arch Oral Biol 2009;54:91-100.
61. Inzitari R, Cabras T, Pisano E, et al. HPLC-ESI-MS analysis of oral human fluids reveals that gingival crevicular fluid is the main source of oral thymosins beta(4) and beta(10). J Sep Sci 2009;32:57-63.
62. Badamchian M, Damavandy A, Damavandy H, et al. Identification and quantification of thymosin beta4 in human saliva and tears. Ann N Y Acad Sci 2007;1112:458-65.
63. Sayer R, Law E, Connelly PJ, et al. Association of a salivary acetylcholinesterase with Alzheimer's disease and response to cholinesterase inhibitors. Clin Biochem 2004;37:98-104.
64. Arana C, Cutando A, Ferrera MJ, et al. Parameters of oxidative stress in saliva from diabetic and parenteral drug addict patients. J Oral Pathol Med 2006;35:554-9.
65. Rao PV, Reddy AP, Lu X, et al. Proteomic identification of salivary biomarkers of type-2 diabetes. J Proteome Res 2009;8:239-45.
66. Walz A, Odenbreit S, Stühler K, et al. Identification of glycoprotein receptors within the human salivary proteome for the lectin-like BabA and SabA adhesins of Helicobacter pylori by fluorescence-based 2-D bacterial overlay. Proteomics 2009;9:1582-92.
67. Grigoriev IV, Nikolaeva LV, Artamonov ID. Protein content of human saliva in various psychoemotional states. Biochemistry (Mosc) 2003;68:405-6.
68. Johannsen A, Rylander G, Söder B, et al. Dental plaque, gingival inflammation, and elevated levels of interleukin-6 and cortisol in gingival crevicular fluid from women with stress-related depression and exhaustion. J Periodontol 2006;77:1403-9.
69. Cabras T, Pisano E, Mastinu A, et al. Alteration of the salivary peptidome profile in children affected by type 1 diabetes. Mol Cell Proteomics 2010;9:2099-108.
70. Castagnola M, Messana I, Inzitari R, et al. Hypo-phosphorylation of salivary peptidome as a clue to the molecular pathogenesis of autism spectrum disorders. J Proteome Res 2008;7:5327-32.
71. Imanguli MM, Atkinson JC, Harvey KE, et al. Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation. Exp Hematol 2007;35:184-92.
72. Ozbay Y, Aydin S, Dagli AF, et al. Obestatin is present in saliva: alterations in obestatin and ghrelin levels of saliva and serum in ischemic heart disease. BMB Rep 2008;41:55-61.
73. Choolani M, Narasimhan K, Kolla V, et al. Proteomic technologies for prenatal diagnostics: advances and challenges ahead. Expert Rev Proteomics 2009;6:87-101.
74. Nemolato S, Messana I, Cabras T, et al. Thymosin beta(4) and beta(10) levels in pre-term newborn oral cavity and foetal salivary glands evidence a switch of secretion during foetal development. PLoS One 2009;4:e5109.